taurine has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 12 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Taurine alleviated mechanical allodynia, mechanical hyperalgesia, and thermal hyperalgesia in CCI rats and suppressed mechanical allodynia and hyperalgesia in diabetic rats." | 3.77 | Antinociceptive effect of intrathecal administration of taurine in rat models of neuropathic pain. ( Hara, K; Haranishi, Y; Sata, T; Terada, T, 2011) |
| "Taurine has been found to ameliorate the diabetic neuropathy and control apoptosis in various tissues." | 1.51 | Protective Effect of Taurine on Apoptosis of Spinal Cord Cells in Diabetic Neuropathy Rats. ( Li, K; Piao, F; Shahbaz, M; Shi, X; Suleman, R; Taj, A; Wu, P; Zhang, M, 2019) |
| "The etiology of painful diabetic neuropathy is poorly understood, but may result from neuronal hyperexcitability secondary to alterations of Ca2+ signaling in sensory neurons." | 1.33 | Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats. ( Abatan, O; Larkin, D; Li, F; Obrosova, IG; Stevens, MJ; Stuenkel, EL; Tian, D, 2005) |
| "Flurbiprofen treatment of ND rats replicated many of the biochemical and physiological abnormalities of EDN, i." | 1.31 | Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration. ( Greene, DA; Larkin, D; Li, F; Marinescu, V; Pop-Busui, R; Stevens, MJ; Sullivan, K; Van Huysen, C, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, K | 3 |
| Shi, X | 3 |
| Luo, M | 1 |
| Wu, P | 3 |
| Zhang, M | 3 |
| Zhang, C | 1 |
| Li, Q | 1 |
| Wang, Y | 1 |
| Piao, F | 3 |
| Suleman, R | 2 |
| Shahbaz, M | 1 |
| Taj, A | 1 |
| Qiu, Z | 1 |
| Aadil, RM | 1 |
| Agca, CA | 1 |
| Tuzcu, M | 1 |
| Hayirli, A | 1 |
| Sahin, K | 1 |
| Askwith, T | 1 |
| Zeng, W | 1 |
| Eggo, MC | 1 |
| Stevens, MJ | 6 |
| Ivanov, DA | 1 |
| Gnusaev, SF | 1 |
| Elizarova, EP | 1 |
| Iakovlev, BN | 1 |
| Terada, T | 1 |
| Hara, K | 1 |
| Haranishi, Y | 1 |
| Sata, T | 1 |
| Pop-Busui, R | 2 |
| Marinescu, V | 1 |
| Van Huysen, C | 3 |
| Li, F | 2 |
| Sullivan, K | 1 |
| Greene, DA | 2 |
| Larkin, D | 2 |
| Obrosova, IG | 2 |
| Abatan, O | 1 |
| Tian, D | 1 |
| Stuenkel, EL | 1 |
| Lattimer, SA | 1 |
| Kamijo, M | 1 |
| Sima, AA | 1 |
| Sullivan, KA | 1 |
| Bayer, L | 1 |
| Cao, X | 1 |
| Towns, R | 1 |
| Fathallah, L | 1 |
1 review available for taurine and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Taurine ameliorates neuropathy via regulating NF-κB and Nrf2/HO-1 signaling cascades in diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Heme Oxygenase-1; NF-E2-Related Fac | 2014 |
11 other studies available for taurine and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Taurine protects against myelin damage of sciatic nerve in diabetic peripheral neuropathy rats by controlling apoptosis of schwann cells via NGF/Akt/GSK3β pathway.
Topics: Animals; Apoptosis; Demyelinating Diseases; Diabetes Mellitus, Experimental; Diabetic Neuropathies; | 2019 |
Protective Effect of Taurine on Apoptosis of Spinal Cord Cells in Diabetic Neuropathy Rats.
Topics: Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Male; Rats; Rats, Spragu | 2019 |
The microRNAs Expression Profile in Sciatic Nerves of Diabetic Neuropathy Rats After Taurine Treatment by Sequencing.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; MicroRNAs; Rats; Sciatic Nerve; Tau | 2019 |
Oxidative stress and dysregulation of the taurine transporter in high-glucose-exposed human Schwann cells: implications for pathogenesis of diabetic neuropathy.
Topics: Aldehyde Reductase; Antioxidants; Biological Transport; Cells, Cultured; Diabetic Neuropathies; Dose | 2009 |
[Efficacy of metabolic therapy in prevention and treatment of adolescents with diabetic autonomic cardiovascular neuropathy].
Topics: Adolescent; Blood Pressure; Chemoprevention; Child; Diabetes Mellitus, Type 1; Diabetic Neuropathies | 2010 |
Antinociceptive effect of intrathecal administration of taurine in rat models of neuropathic pain.
Topics: Analgesics; Animals; Behavior, Animal; Diabetic Neuropathies; Disease Models, Animal; Dose-Response | 2011 |
Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration.
Topics: Acetylcarnitine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase | 2002 |
Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats.
Topics: Adenosine Triphosphate; Animals; Blood Glucose; Body Weight; Caffeine; Calcium Signaling; Central Ne | 2005 |
Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat.
Topics: Aldehyde Reductase; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic N | 1993 |
Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
Topics: Animals; Anti-Bacterial Agents; Blood Flow Velocity; Blood Glucose; Blood Pressure; Body Weight; Car | 2001 |
Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy.
Topics: Aldehydes; Animals; Ascorbic Acid; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diab | 2001 |